| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1007/S11239-007-0101-1 |
| P698 | PubMed publication ID | 17906918 |
| P2093 | author name string | Maria I Aguilar | |
| Robert G Hart | |||
| P2860 | cites work | Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation | Q22305336 |
| ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation | Q22306351 | ||
| Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial | Q26248603 | ||
| Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation | Q28165271 | ||
| Transient ischemic attacks in patients with atrial fibrillation: implications for secondary prevention: the European Atrial Fibrillation Trial and Stroke Prevention in Atrial Fibrillation III trial | Q28167478 | ||
| Avoiding central nervous system bleeding during antithrombotic therapy: recent data and ideas | Q28176992 | ||
| Optimal INR for prevention of stroke and death in atrial fibrillation: a critical appraisal | Q28195525 | ||
| Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation | Q28210235 | ||
| Secondary stroke prevention with ximelagatran versus warfarin in patients with atrial fibrillation: pooled analysis of SPORTIF III and V clinical trials | Q28218311 | ||
| Rationale and design of ACTIVE: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events | Q28219191 | ||
| Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial | Q28219363 | ||
| Use of factor IX complex in warfarin-related intracranial hemorrhage | Q28375864 | ||
| Intracerebral hemorrhage associated with oral anticoagulant therapy: current practices and unresolved questions | Q36336888 | ||
| Treatment of warfarin-associated intracerebral hemorrhage: literature review and expert opinion. | Q36730433 | ||
| Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care a | Q36810929 | ||
| Timing of fresh frozen plasma administration and rapid correction of coagulopathy in warfarin-related intracerebral hemorrhage | Q39737359 | ||
| Oral anticoagulants and intracranial hemorrhage. Facts and hypotheses. | Q40458214 | ||
| Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators | Q43764537 | ||
| Canadian atrial fibrillation anticoaguiation (CAFA) study | Q43928649 | ||
| The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation | Q44153210 | ||
| Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial | Q44672192 | ||
| Effects of a perindopril-based blood pressure-lowering regimen on the risk of recurrent stroke according to stroke subtype and medical history: the PROGRESS Trial | Q44690382 | ||
| Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial | Q45258336 | ||
| The lowest effective intensity of prophylactic anticoagulation for patients with atrial fibrillation | Q46592441 | ||
| Perindopril-based blood pressure-lowering reduces major vascular events in patients with atrial fibrillation and prior stroke or transient ischemic attack | Q46686096 | ||
| The increasing incidence of anticoagulant-associated intracerebral hemorrhage | Q48315722 | ||
| An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation | Q48940645 | ||
| Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study. | Q54114563 | ||
| Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial | Q56659254 | ||
| Stroke Prevention in Atrial Fibrillation Study. Final results | Q67925848 | ||
| Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. EAFT (European Atrial Fibrillation Trial) Study Group | Q72657107 | ||
| P433 | issue | 1 | |
| P921 | main subject | atrial fibrillation | Q815819 |
| anticoagulation | Q63279445 | ||
| P1104 | number of pages | 7 | |
| P304 | page(s) | 26-32 | |
| P577 | publication date | 2007-09-29 | |
| P1433 | published in | Journal of Thrombosis and Thrombolysis | Q15766541 |
| P1476 | title | Anticoagulation in atrial fibrillation: selected controversies including optimal anticoagulation intensity, treatment of intracerebral hemorrhage | |
| P478 | volume | 25 |
| Q42851409 | Advances in the prevention of cerebral ischaemia due to atrial fibrillation |
| Q79805865 | Early complications of ischemic stroke |
| Q53459076 | Left atrial appendage closure with amplatzer cardiac plug in atrial fibrillation: Initial european experience |
| Q42867752 | Persistent left atrial thrombus in atrial fibrillation under oral anticoagulation |
| Q26866343 | Prevention of cardioembolic stroke |
| Q30277799 | The Insertion and Management of External Ventricular Drains: An Evidence-Based Consensus Statement : A Statement for Healthcare Professionals from the Neurocritical Care Society |
| Q35121230 | Treatments for reversing warfarin anticoagulation in patients with acute intracranial hemorrhage: a structured literature review |
| Q44712997 | Unique evolution of Bivalvia arginine kinases |
| Q48905557 | Warfarin associated intracerebral hemorrhage in Hong Kong Chinese |
| Q37063465 | Warfarin reversal in anticoagulant-associated intracerebral hemorrhage |
| Q37238957 | Warfarin-associated intracerebral hemorrhage |
Search more.